GPCRsのナトリウムイオンによるアロステリック調節の構造的基礎
Wei Liu1, Eugene Chun, Aaron A Thompson
1Department of Molecular Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.
まとめ
Gタンパク質結合受容体 (GPCR) の高解像度構造は,受容体機能における水,ナトリウムイオン,脂質の重要な役割を明らかにしています. この研究は,アデノシンA2A受容体の安定した構造を詳細に説明し,GPCR調節に関する新しい洞察を提供します.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- 薬理学 薬理学とは
背景:
- Gタンパク質結合受容体 (GPCRs) は重要な薬物の標的ですが,それらの構造の研究はしばしば中等解像度で制限されます.
- アロステリック調節剤は,GPCRの薬理学的反応を微調整し,詳細な構造的理解を必要とします.
研究 の 目的:
- 人間のアデノシンA2A受容体の高解像度構造を決定する.
- GPCRの構造と機能における内部水分子,イオン,脂質の役割を調査する.
主な方法:
- 人間のアデノシンA2A受容体を再設計し,その第3の細胞内ループをアポサイトクロームbで置き換える.
- X線結晶学を用いて,受容体の構造を1.8アングストームの解像度で解く.
主要な成果:
- 受容体内で3つのクラスターを形成する57の秩序付けられた水分子の識別.
- Asp ((2.50) と結合した推定ナトリウムイオンの局所化と,2つのコレステロールによってヘリックスVIの安定化.
- リガンド結合ポケット内の脂質のインターカレーションの観察.
結論:
- 高解像度構造の詳細は,GPCR安定化における構造水,ナトリウムイオン,脂質/コレステロールの潜在的な役割を明らかにしています.
- これらの発見は,アロステル調節を理解し,GPCRを標的とした新しい治療法を開発するための基盤を提供します.
関連する概念動画
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...


